Taisho Pharmaceutical Holdings Co., Ltd.

TAIPY · OTC
Analyze with AI
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Assets
Cash & Equivalents$255,966$265,049$250,178$223,814
Short-Term Investments$200$7,219$4,017$14,089
Receivables$51,925$53,265$51,176$65,014
Inventory$53,331$44,891$46,383$43,369
Other Curr. Assets$14,458$8,440$5,977$9,337
Total Curr. Assets$375,880$378,864$357,731$355,623
Property Plant & Equip (Net)$141,170$119,291$113,194$112,555
Goodwill$128,051$125,769$128,612$169,862
Intangibles$110,441$87,290$87,920$40,118
Long-Term Investments$163,216$146,405$164,299$143,386
Tax Assets$6,761$9,508$8,892$11,134
Other NC Assets$15,968$21,028$16,271$20,369
Total NC Assets$565,607$509,291$519,188$497,424
Other Assets$3$4$4$4
Total Assets$941,490$888,159$876,923$853,051
Liabilities
Payables$17,001$15,101$14,672$18,045
Short-Term Debt$0$2,289$1,587$1,814
Tax Payable$1,889$3,579$3,275$5,414
Deferred Revenue$0$246-$1,587-$1,814
Other Curr. Liab.$54,888$41,308$38,132$41,183
Total Curr. Liab.$73,778$62,277$57,666$66,456
LT Debt$0$0$0$0
Deferred Rev, NC$350$550$0$0
Deferred Tax Liab, NC$32,801$29,162$32,747$16,943
Other NC Liab.$26,014$28,763$28,106$27,946
Total NC Liab.$59,165$57,925$60,853$44,889
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$132,943$120,202$118,519$111,345
Equity
Pref Stock$0$0$0$0
Common Stock$30,000$30,000$30,000$30,000
Retained Earnings$713,776$702,984$703,036$699,412
AOCI$63,853$36,198$31,907$17,378
Other Equity-$21,062-$21,033-$35,438-$16,147
Total Equity$786,567$748,151$729,504$712,076
Supplemental Information
Minority Interest$22,776$19,806$28,900$29,630
Total Liab. & Tot. Equity$941,490$888,159$876,923$853,051
Net Debt-$255,966-$262,760-$248,591-$222,000
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Financial Statements & Key Stats | AlphaPilot